BioSante Pharmaceuticals, Inc. (BPAX)

[OptionsBoy]

They may be not buying so that they will be free and clear of any claims of "manipulating" the stock for profit. I think the Libigel failure totally floored them, that they weren't expecting it in the slightest, and are working out what was flawed in their testing, and this latest extension trial will have positive results.

I still believe Libigel has a legitimate chance of being successful and approved, I think they may hold off buying more until they release any final results from Libigel. Imagine the strength that will show if they wait for the stock price to recover and then start adding heavily.

I saw the stock has never traded below $1.20 a share even before Libigel came along, so the stock should be worth at least that.

Imagine in February if Bio-T-Gel gets full approval and the Libigel extension trial comes back with positive results. Easily looking at $3-4+ a share.

Upside potential is too huge. Even if you don't believe, the possibility of what is ahead will send this up past $1 and possibly closer to $2 by mid Feb.